Natural history of HIV infected pediatric long-term or slow progressor population after the first decade of life

Pediatric Infectious Disease Journal

Volumn 26, Issue 3, 2007, Pages 217-220

  Ofori Mante, Juliana A ^a   Kaul, Aditya ^a   Rigaud, Mona ^a   Fidelia, Andre ^a   Rochford, Gemma ^a   Krasinski, Keith ^a   Chandwani, Sulachni ^a   Borkowsky, William ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV; Long term nonprogressors; Natural history; Slow progressors; Thymic receptor excision circles

Indexed keywords

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL PROCEDURES; MALE; MEDICAL RECORD; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PUBERTY; RACE; VIRUS LOAD;

ADOLESCENT; AGING; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CHILD; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; MALE; THYMUS GLAND;

EID: 33847345135     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000254413.11246.e1     Document Type: Article

References (20)

1. Sheppard HW, Lang W, Ascher MS, Vittinghoff E, Winkelstein W. The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels. AIDS. 1993;7:1159-1166.
2. Levy JA. HIV pathogenesis and long-term survival. AIDS. 1993;7:1401-1410.
3. Casartelli N, Di Matteo G, Argentini C, et al. Structural defects and variations in the HIV-1 nef gene from rapid, slow and non-progressor children. AIDS. 2003;17:1291-1301.
4. Turci M, Pilotti E, Ronzi P, et al. Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS. J Acquir Immune Defic Syndr. 2006;41:100-106.
5. Aldrovandi GM, Feuer G, Gao L, et al. The SCID-hu mouse as a model for HIV-1 infection. Nature. 1993;363:732-736.
6. Sharland M, Watkins AM, Dalgleish AG, Cammack N, Westby M. Immune reconstitution in HAART-treated children with AIDS: highly active anti-retroviral therapy. Lancet. 1998;352:577-578.
7. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998;396:690-695.
8. Zhang L, Lewin SR, Markowitz M, et al. Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy. J Exp Med. 1999;190:725-732.
9. Kostrikis LG, Huang Y, Moore JP, et al. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med. 1998;4:350-353.
10. Haynes BF, Markert ML, Sempowski GD, Patel DD, Hale LP. The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Annu Rev Immunol. 2000;18:529-560.
11. Pham T, Belzer M, Church JA, et al. Assessment of thymic activity in human immunodeficiency virus-negative and -positive adolescents by real-time PCR quantitation of T-cell receptor rearrangement excision circles. Clin Diagn Lab Immunol. 2003;10:323-328.
12. Pahwa S, Chitnis V, Mitchell RM, et al. CD4+ and CD8+ T cell receptor repertoire perturbations with normal levels of T cell receptor excision circles in HIV-infected, therapy-naive adolescents. AIDS Res Hum Retroviruses. 2003;19:487-495.
13. Chakraborty R, Morel AS, Sutton JK, et al. Correlates of delayed disease progression in HIV-1-infected Kenyan children. J Immunol. 2005;174:8191-8199.
14. Wu L, Paxton WA, Kassam N, et al. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med. 1997;185:1681-1691.
15. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science. 1996;273:1856-1862.
16. Martinson JJ, Chapman NH, Rees DC, Liu YT, Clegg JB. Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet. 1997;16:100-103.
17. Magierowska M, Lepage V, Boubnova L, et al. Distribution of the CCR5 gene 32 base pair deletion and SDF1-3′ A variant in healthy individuals from different populations. Immunogenetics. 1998;48:417-419.
18. Koot M, Keet IP, Vos AH, et al. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med. 1993;118:681-688.
19. Salvini F, Scarlatti G, Bossi A, et al. Follow-up of vertically HIV-1-infected long-surviving children. AIDS Patient Care STDS. 2001;15:59-65.
20. Alexander L, Cuchura L, Simpson BJ, Andiman WA. Virologic and host characteristics of human immunodeficiency virus type 1-infected pediatric long-term survivors. Pediatr Infect Dis J. 2006;25:135-41.